Abstract

Simple SummaryYoung adult survivors of colorectal cancer often undergo intensive and multimodal cancer therapy and may experience impairments in health-related quality of life. However, knowledge regarding the impacts of colorectal cancer on the quality of life of young adults is limited. This study aimed to characterize overall health-related quality of life among young adult colorectal cancer survivors within 36 months of their diagnosis or relapse, to compare those who are shorter versus longer time from initial diagnosis or relapse, and to examine correlates across the distinct domains of quality of life. Such information can inform the development of life stage-appropriate counseling and interventions to maintain and improve health-related quality of life following a colorectal cancer diagnosis for this at-risk patient population.The incidence of colorectal cancer (CRC) is rising among young adults. Health-related quality of life (HRQoL) in survivorship is not well-described in this population. We assessed HRQoL among young adult CRC survivors diagnosed from age 18–39 (AYAs) to examine differences by time from diagnosis, and to identify key correlates. A cross-sectional online survey was administered in collaboration with a national patient advocacy organization. The Functional Assessment of Cancer Therapy (FACT-C) was used to measure HRQoL, which assesses HRQoL globally and across 4 domains: emotional, physical, social, and functional. T-tests were conducted to compare HRQoL between survivors who were 6–18 months versus 19–36 months from diagnosis or relapse and multiple linear regression was conducted to identify correlates. The sample (n = 196) had a mean age of 32.2(SD ± 4.5); 116 (59.9%) were male; and the self-reported tumor location was colon (39.3%) or rectal (60.7%). The majority (56.4%) were diagnosed with stage 2 disease; 96.9% were non-metastatic. The mean global HRQoL score was 67.7 out of a possible score of 136. Across domains, mean scores were low. Emotional and physical well-being were significantly higher among survivors who were 19–36 months from diagnosis/relapse compared to those 6–18 months from diagnosis/relapse. Longer time from diagnosis and older current age were associated with higher HRQoL, while more intensive treatment and higher clinical disease stage were negatively associated, particularly in the emotional and physical domains. Overall, HRQoL was low in this population, and further research is needed to inform age-appropriate interventions to improve HRQoL for AYA CRC survivors.

Highlights

  • Over the past two decades, the significant medical and psychosocial challenges facing adolescent and young adults (AYAs; diagnosed at ages 15–39) with cancer have received considerable attention [1]

  • The aim of the current study was to characterize Health-related quality of life (HRQoL) among AYA colorectal cancer (CRC) survivors diagnosed between the ages of 18–39 and who were in early survivorship (6–36 months from their diagnosis or relapsed disease)

  • 60% of survivors in the current sample were male compared to approximately 52% of incident cases in 2010–2015 SEER data [31].The study sample, reflected survivors with earlier stage disease and a greater proportion of males compared to SEER data

Read more

Summary

Introduction

Over the past two decades, the significant medical and psychosocial challenges facing adolescent and young adults (AYAs; diagnosed at ages 15–39) with cancer have received considerable attention [1]. While incidence rates of CRC in the last decade have dropped by 1.4% per year among individuals aged 50 to years and by 4.0% per year among those aged years and older, rates have risen in adults aged 50 years and older by 1.6% annually, increasing by 22% overall during this time period [9]. Compared to those born in 1950, individuals born circa 1990 ( AYAs, ~age 31) have double the risk of colon cancer and quadruple the risk of rectal cancer [10]. Based on the increased incidence of CRC among young adults, the U.S Preventive Services Task Force (USPSTF) issued a revision of screening guidelines in 2021 to lower the starting age of colonoscopy from 50 to 45 years old [11]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call